HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS
Skip to content
MS Speaks
Light
Dark
System
Login
Register
Menu
Home
Contact
MS Speaks
Forum
Multiple Sclerosis
TREATMENTS
LEMTRADA (Campath, alemtuzumab)
Pages: [
1
]
2
Sort by: Last post
Subject
Started by
Replies
Views
Last post
0 Members and 0 Guests are viewing this board.
A
(Abst.) Siponimod following alemtuzumab for SPMS...
(Abst.) Siponimod following alemtuzumab for SPMS...
agate
·
August 18, 2024, 11:36:27 am
From PubMed (August 18, 2024)--"Siponimod following alemtuzumab for secondary progressive multiple sclerosis: Investigating sequ...
0 Replies · 363 Views
Started by
agate
0
Replies
363
Views
A
agate
Aug 18, 2024
A
Impact of previous DMT on effectiveness, safety outcomes in PwMS treated w/Lemtrada
Impact of previous DMT on effectiveness, safety outcomes in PwMS treated w/Lemtrada
agate
·
April 05, 2021, 03:17:30 pm
From the Journal of Neurology, Neurosurgery and Psychiatry (April 5, 2021), "Impact of previous disease-modifying treatment on ...
0 Replies · 417 Views
Started by
agate
0
Replies
417
Views
A
agate
Apr 5, 2021
A
(Abst.) Alemtuzumab and rx medication use in the MS population
(Abst.) Alemtuzumab and rx medication use in the MS population
agate
·
May 14, 2020, 10:01:41 am
This study indicates that people with MS taking alemtuzumab are also highly likely to be taking quite a few prescription drugs. ...
0 Replies · 410 Views
Started by
agate
0
Replies
410
Views
A
agate
May 14, 2020
A
(Abst.) Acute cardiotoxicity associated w/alemtuzumab infusion for MS
(Abst.) Acute cardiotoxicity associated w/alemtuzumab infusion for MS
agate
·
April 20, 2020, 08:29:55 am
From Multiple Sclerosis Journal (April 20, 2020)--"Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclero...
0 Replies · 443 Views
Started by
agate
0
Replies
443
Views
A
agate
Apr 20, 2020
A
(ACTRIMS) Fatal intercerebral hemorrhage secondary to alemtuzumab
(ACTRIMS) Fatal intercerebral hemorrhage secondary to alemtuzumab
agate
·
March 14, 2020, 03:06:02 pm
Abstract of a paper presented at the recent (February 27-29) ACTRIMS conference, entitled "Fatal intercerebral hemorrhage second...
0 Replies · 448 Views
Started by
agate
0
Replies
448
Views
A
agate
Mar 14, 2020
A
(Abst.) ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for MS
(Abst.) ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for MS
agate
·
February 23, 2020, 03:20:27 pm
From PubMed (February 23, 2020), "ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple ...
0 Replies · 435 Views
Started by
agate
0
Replies
435
Views
A
agate
Feb 23, 2020
A
Refractory chronic spontaneous urticaria after Lemtrada in MS
Refractory chronic spontaneous urticaria after Lemtrada in MS
agate
·
January 10, 2020, 09:18:32 pm
This is the entire (short) article in Neurology (January 2020) by researchers in Australia--entitled "Refractory chronic spontan...
0 Replies · 277 Views
Started by
agate
0
Replies
277
Views
A
agate
Jan 10, 2020
A
(Abst.) Alemtuzumab-induced lung injury in 3 MS patients
(Abst.) Alemtuzumab-induced lung injury in 3 MS patients
agate
·
November 03, 2019, 07:27:43 pm
From PubMed (November 2, 2019), "Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patient...
0 Replies · 353 Views
Started by
agate
0
Replies
353
Views
A
agate
Nov 3, 2019
A
(MS Journal editorial) Emerging safety issues in alemtuzumab-treated MS patients
(MS Journal editorial) Emerging safety issues in alemtuzumab-treated MS patients
agate
·
August 02, 2019, 02:55:41 pm
An editorial with cautions about Lemtrada--"Emerging safety issues in alemtuzumab-treated MS patients" in Multiple Sclerosis Jou...
0 Replies · 366 Views
Started by
agate
0
Replies
366
Views
A
agate
Aug 2, 2019
A
EMA to restrict use of alemtuzumab pending review
EMA to restrict use of alemtuzumab pending review
agate
·
May 14, 2019, 04:34:57 pm
The concern about stroke risk has prompted the European Medicines Agency to restrict the use of alemtuzumab pending review. From...
0 Replies · 321 Views
Started by
agate
0
Replies
321
Views
A
agate
May 14, 2019
A
Alemtuzumab under scrutiny because of risk of stroke in some patients with MS
Alemtuzumab under scrutiny because of risk of stroke in some patients with MS
agate
·
April 26, 2019, 07:15:37 am
The Lancet (April 27, 2019) contains an article on this topic though there is no easy access to it. However, another article (fr...
0 Replies · 449 Views
Started by
agate
0
Replies
449
Views
A
agate
Apr 26, 2019
A
(Abst.) Autoimmune nephropathies after Lemtrada treatment in PwMS
(Abst.) Autoimmune nephropathies after Lemtrada treatment in PwMS
agate
·
April 22, 2019, 02:42:03 pm
From Multiple Sclerosis Journal (April 15, 2019), "Incidence, management, and outcomes of autoimmune nephropathies following ale...
0 Replies · 347 Views
Started by
agate
0
Replies
347
Views
A
agate
Apr 22, 2019
A
(Abst.) Immune profiling of a patient w/alemtuzumab-associated PML
(Abst.) Immune profiling of a patient w/alemtuzumab-associated PML
agate
·
April 10, 2019, 04:24:57 pm
From PubMed (April 10, 2019), "Immune profiling of a patient w/alemtuzumab-associated PML": http://bit.ly/2IdR0WO
0 Replies · 365 Views
Started by
agate
0
Replies
365
Views
A
agate
Apr 10, 2019
A
(Abst.) Neutropenia w/fatal outcome in MS patient 23 days after alemtuzumab infusion
(Abst.) Neutropenia w/fatal outcome in MS patient 23 days after alemtuzumab infusion
agate
·
July 23, 2018, 07:49:08 pm
From Multiple Sclerosis and Related Disorders (July 2018), "Neutropenia with fatal outcome in a multiple sclerosis patient 23 da...
0 Replies · 448 Views
Started by
agate
0
Replies
448
Views
A
agate
Jul 23, 2018
A
More risks emerge for alemtuzumab in MS
More risks emerge for alemtuzumab in MS
agate
·
April 08, 2018, 04:27:28 pm
From MedPage Today, "More risks emerge for alemtuzumab in MS" (April 6, 2018):[url]https://www.medpagetoday.com/neurology/multip...
0 Replies · 371 Views
Started by
agate
0
Replies
371
Views
A
agate
Apr 8, 2018
A
(Absts.) Two adverse events with Lemtrada reported
(Absts.) Two adverse events with Lemtrada reported
agate
·
January 29, 2018, 06:40:19 pm
From Multiple Sclerosis Journal, January 23, 2018--"Life-threatening autoimmune warm hemolytic anemia following treatment for mu...
0 Replies · 494 Views
Started by
agate
0
Replies
494
Views
A
agate
Jan 29, 2018
A
(Abst.) Decreased platelet number in MS during alemtuzumab infusion...
(Abst.) Decreased platelet number in MS during alemtuzumab infusion...
agate
·
January 25, 2018, 04:31:23 pm
"Decreased platelet number in multiple sclerosis during alemtuzumab infusion: A common, transient, and clinically silent phenome...
0 Replies · 437 Views
Started by
agate
0
Replies
437
Views
A
agate
Jan 25, 2018
A
(Abst.) Activation of MS during Lemtrada therapy in 3 patients w/MS
(Abst.) Activation of MS during Lemtrada therapy in 3 patients w/MS
agate
·
January 21, 2018, 03:41:12 pm
From PubMed (January 21, 2018)-- "Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis":h...
0 Replies · 406 Views
Started by
agate
0
Replies
406
Views
A
agate
Jan 21, 2018
A
(Abst.) Alemtuzumab in MS: Lessons from social media in enhancing patient care
(Abst.) Alemtuzumab in MS: Lessons from social media in enhancing patient care
agate
·
December 23, 2017, 08:57:09 am
From PubMed, December 23, 2017:QuoteInt J MS Care. 2017 Nov-Dec;19(6):323-328. Alemtuzumab in Multiple Sclerosis: Lessons from S...
0 Replies · 477 Views
Started by
agate
0
Replies
477
Views
A
agate
Dec 23, 2017
A
Induction of new autoimmune diseases after alemtuzumab therapy for MS: Learning from adversity
Induction of new autoimmune diseases after alemtuzumab therapy for MS: Learning from adversity
agate
·
June 12, 2017, 08:40:12 pm
An editorial in JAMA Neurology, June 12, 2017, seems to be trying to find something positive about the diseases like PML that cr...
0 Replies · 419 Views
Started by
agate
0
Replies
419
Views
A
agate
Jun 12, 2017
Pages: [
1
]
2
MS Speaks
Forum
Multiple Sclerosis
TREATMENTS
LEMTRADA (Campath, alemtuzumab)
Home
Search
Login
Register
Menu
Login
×
Welcome,
Guest
. Please
login
or
register
.
Username
Password
Session Length
1 Hour
1 Day
1 Week
1 Month
Forever
Login with username, password and session length
or continue with
Login with your social network
